✦ LIBER ✦
4526 POSTER Safety profile of single-agent sunitinib malate from the French Temporary Authorization for Use program (Cohort ATU) in metastatic renal cell carcinoma (MRCC) after failure of treatment with cytokines and gastrointestinal stromal tumor (GIST) patients after failure of imatinib mesylate treatment
✍ Scribed by Oudard, S.; Negrier, S.; Ferrero, J.M.; Gravis, G.; Blay, J.Y.; Le Cesne, A.; Krulik, J.; Mahi, N.; Rixe, O.
- Book ID
- 123169784
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 58 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.